Improved performance with saliva and urine as alternative DNA sources for malaria diagnosis by mitochondrial DNA-based PCR assays  by Putaporntip, C. et al.
Improved performance with saliva and urine as alternative DNA
sources for malaria diagnosis by mitochondrial DNA-based PCR assays
C. Putaporntip, P. Buppan and S. Jongwutiwes
Department of Parasitology, Faculty of Medicine, Molecular Biology of Malaria and Opportunistic Parasites Research Unit, Chulalongkorn University, Bangkok,
Thailand
Abstract
Saliva and urine from malaria-infected individuals contain trace amounts of Plasmodium DNA, and therefore, could be used as alternative
specimens for diagnosis. A nested PCR targeting the mitochondrial cytochrome b gene (Cytb-PCR) of four human malaria species and
Plasmodium knowlesi was developed and tested with 693 blood samples from febrile patients living in diverse malaria-endemic areas of
Thailand, and compared with microscopy and nested PCR targeting small-subunit rRNA (18S-PCR). Cytb-PCR was 16% and 39.8% more
sensitive than 18S-PCR and microscopy, respectively, in detecting all of these malarial species in blood samples. Importantly, 34% and
17% of Plasmodium falciparum and Plasmodium vivax mono-infections, respectively, detected by microscopy were, in fact, mixed P. falcipa-
rum and P. non-falciparum infections. Analysis of matched blood, saliva and urine from 157 individuals showed that microscopy and Cytb-
PCR of saliva yielded no signiﬁcant difference in detecting P. falciparum and P. vivax. However, Cytb-PCR of saliva was more sensitive
than microscopy for diagnosis of mixed-species infections. A combination of Cytb-PCR of saliva and of urine signiﬁcantly outperformed
microscopy (p 0.0098 for P. falciparum, p 0.006 for P. vivax, and p 0.0002 for mixed infections). Furthermore, Plasmodium malariae and
P. knowlesi could also be identiﬁed in saliva and urine with this method. Therefore, the Cytb-PCR developed herein offers a high poten-
tial for the use of both saliva and urine for malaria diagnosis, with a sensitivity comparable with or superior to that of microscopy.
Keywords: Malaria diagnosis, mitochondrial cytochrome b, nested PCR, Plasmodium knowlesi, saliva, urine
Original Submission: 26 October 2010; Revised Submission: 1 Febuary 2011; Accepted: 17 Febuary 2011
Editor: G. Greub
Article published online: 14 March 2011
Clin Microbiol Infect 2011; 17: 1484–1491
10.1111/j.1469-0691.2011.03507.x
Corresponding author: C. Putaporntip, Department of Parasitol-
ogy, Faculty of Medicine, Molecular Biology of Malaria and Opportu-
nistic Parasites Research Unit, Chulalongkorn University, Bangkok,
Thailand
E-mail: p.chaturong@gmail.com
Introduction
Naturally acquired malaria infections in humans can be caused
by one or more of four human Plasmodium species and Plasmo-
dium knowlesi, a non-human primate pathogen of macaques in
Southeast Asia [1–3]. Accurate diagnosis of malaria is a funda-
mental step in the proper management of infected individuals,
prevention of mortality, disease surveillance, and control mea-
sures. The application of PCR for malaria detection has
revealed a number of cryptic infections and co-infections with
malarial species in several endemic areas [2–4]. Despite
remarkable progress in the development of diagnostic tools
for malaria, all require blood samples to be taken from patients
[3–5]. Although sampling of blood from individuals suspected
of having malaria does not usually have severe consequences if
performed with strict aseptic precautions, certain groups in
the population, such as infants, small children, and some preg-
nant women, may not cooperate well when repeated blood
sample collection is mandatory [6]. Therefore, a non-invasive
specimen collection method that can substitute for blood sam-
ple collection, with a comparable diagnostic performance to
that of microscopy, will offer a better opportunity to cover all
subjects in need of investigation or diagnosis.
Saliva and urine samples of Plasmodium falciparum-infected
and Plasmodium vivax-infected patients have been shown to
contain malarial DNA that is ampliﬁable by PCR [7,8]. How-
ever, only trace amounts of malarial DNA could be found in
saliva and urine, two orders of magnitude and three orders
of magnitude, respectively, less than that in concurrent blood
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samples of infected individuals, an issue that potentially
constrains their usefulness in diagnosis [9]. For example, the
sensitivities of P. falciparum detection in saliva samples from
patients in Thailand and The Gambia by nested PCR target-
ing malarial small-subunit rRNA (18S-PCR) were 74.1% and
73%, respectively, when compared with microscopy, whereas
their matched urine samples yielded sensitivities of 44.4%
and 32%, respectively [8,9]. Undoubtedly, a more sensitive
detection method is a prerequisite before these body ﬂuids
can be practically exploited for diagnostic purposes [9].
Protozoans in the genus Plasmodium possess small mito-
chondrial genomes (mtDNA), spanning approximately 6 kb
with a copy number ranging from 30 to 100 per parasite,
whereas only four to eight copies of 18S rRNA are present in
each parasite nucleus [10–12]. Hence, the diagnostic sensitivity
of a PCR assay targeting mtDNA could be superior to that of
an 18S rRNA-based method. The mtDNA sequences of each
malaria species are highly conserved, whereas limited variation
in sequences occurs between species [13]. The cytochrome b
gene (Cytb) is one of the three protein-encoding genes found
in mtDNA, and has been widely used to study phylogenetics
and evolutionary relationships among plasmodia [14]. There-
fore, despite a low level of sequence divergence in comparison
with 18S rRNA, Cytb has a potential role in differentiating
malarial species. In this study, we determined whether the
diagnostic performance with saliva and urine samples from
malaria patients could be improved by our newly developed
PCR method targeting Plasmodium Cytb.
Materials and Methods
Study areas, subjects, and sample collection
Venous blood (approximately 2 mL) or ﬁnger-prick blood
(approximately 200 lL) samples were collected from 593
microscopy-positive malaria patients and 100 microscopy-
negative febrile individuals suspected of having malaria (445
males and 248 females; mean age, 28 years; range, 3–
78 years) at malaria clinics in north-western (Tak Province,
n = 359, 309 positives, 50 negatives), eastern (Chantaburi
Province, n = 163, 138 positives, 25 negatives) and southern
(Yala and Narathiwat Provinces, n = 171, 146 positives, 25
negatives) Thailand from November 2006 to February 2007
and from June to August 2008. Blood samples were collected
into sterile tubes containing EDTA as an anticoagulant, and
kept on ice during transportation from the study sites to
our laboratory at Chulalongkorn University in Bangkok,
where samples were subsequently stored at )40C until use.
Of 359 patients in Tak Province, matched blood, saliva and
urine samples were available from 157 febrile individuals,
comprising 117 microscopy-positive samples and 40 micros-
copy-negative samples. Approximately 1–2 mL of saliva sam-
ple and 20 mL of midstream urine sample were obtained
from each subject immediately after blood sample collection
and prior to antimalarial treatment. Both saliva and urine
samples were preserved by adding approximately two vol-
umes of absolute ethanol, and kept at ambient temperature
(25–35C) until DNA extraction [8]. Exclusion criteria were
previous antimalarial treatment or the presence of clinical
signs and symptoms of severe malaria [15]. Before patients
were enrolled in this study, informed consent was obtained
from each patient or from a parent or guardian for those
aged <18 years. The ethical aspects of this study have been
approved by the Institutional Review Board of the Faculty of
Medicine, Chulalongkorn University.
Microscopy
Examination of Giemsa-stained blood ﬁlms was performed by
a very experienced microscopist, with at least 200 micro-
scopic ﬁelds for thin blood ﬁlms, and at least 200 leukocytes
for thick blood ﬁlms. The parasite density was estimated by
assuming a leukocyte count of 7000/lL [16]. The microsco-
pist and the PCR technician were unaware of the patient’s
diagnosis or other results.
DNA extraction
Isolation of DNA was performed with the Qiagen DNA mini-
kit (Qiagen. Hilden, Germany). For ethanol-preserved urine
and saliva samples, 1 mL of each specimen was centrifuged at
13 500 g at 4C for 10 min, and the upper portion of the sam-
ples was discarded, leaving approximately 30% of the original
volume in the lower portion for DNA extraction [8].
Positive and negative controls
Positive control DNA for P. falciparum was obtained from
clone T9/96, and controls for P. vivax, Plasmodium malariae,
Plasmodium ovale and P. knowlesi were derived from clinical
isolates from single-species infections that had been veriﬁed
by sequence analysis of the mitochondrial genome and the
merozoite surface protein-1 locus [13,17] (C. Putaporntip
and S. Jongwutiwes, unpublished data). Sterile water was
used as a negative control.
Nested PCR targeting 18S rRNA
Detection of the four human malaria species and P. knowlesi
was performed by 18S-PCR, as previously described [3].
Nested PCR targeting mitochondrial CtyB (Cytb-PCR)
The PCR primers were derived from sequence comparison
among CtyB and its 3¢-ﬂanking sequences available in the
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GenBank database of P. falciparum (n = 105), P. vivax
(n = 283), P. malariae (n = 3), P. ovale (n = 7, comprising both
classic and variant types), and P. knowlesi (n = 56). Primers
for primary PCR targeting Plasmodium-speciﬁc Cytb and those
for secondary PCR were speciﬁc for each Plasmodium species
(Table 1). Secondary PCR was performed in separate reac-
tion tubes for each pair of species-speciﬁc primers. DNA
ampliﬁcation was carried out in a total volume of 15 lL con-
taining template DNA, 2.5 mM each deoxynucleoside tri-
phosphate, 1.5 lL of 10 · PCR buffer, 0.3 lM each primer,
and 0.4 units of rTaq DNA polymerase (Takara, Seta, Japan).
Thirty-ﬁve cycles (94C for 40 s, 50C for 30 s, and 72C
for 30 s) were performed for primary PCR, and 25 cycles
for secondary PCR. The ampliﬁcation products were analy-
sed by agarose gel electrophoresis.
Detection limit and speciﬁcity
Ampliﬁcation of mtDNA of each of the ﬁve malaria species
(P. falciparum T9/96 clone and clinical isolates of P. vivax,
P. malariae, P. ovale, and P. knowlesi) was performed as previ-
ously described [13]. After the 6-kb PCR-ampliﬁed products
had been gel-puriﬁed, the concentration of each template
was determined with the NanoDrop apparatus (Thermo
Fisher Scientiﬁc, Delaware, OH, USA). Each mitochondrial
genome of these malaria species contained 5957–5990 bp,
equivalent to 3.05–3.07 · 10)6 pg; thereby, the copy number
of each DNA template could be estimated and decimally
diluted to obtain the minimum of one copy/lL. The dilutions
of 1 · 105, 1 · 104, 1 · 103, 1 · 102, 10 and one copy/lL
were used as templates for determination of the detection
limit of Cytb-PCR. To test whether mixed DNA templates
from different malarial species could inﬂuence the sensitivity
of each PCR assay, artiﬁcially mixed DNA templates from
ﬁve malarial species with substantial differences in copy num-
ber were assessed, i.e. various combinations of one or ten
copies of one species mixed with 1 · 105 copies of the
other four species. For P. falciparum, the detection limit was
also determined by using DNA templates from known num-
bers of highly synchronous cultured parasites that were deci-
mally diluted to obtain DNA template equivalents as low as
one parasite/lL. All procedures were repeated three times.
The speciﬁcity of Cytb-PCR was tested against ﬁve known
isolates of each malarial species. DNA from healthy donors
without a history of malaria exposure was used as a negative
control template for every 15 tested samples.
Data analysis
The diagnostic performance of each test was evaluated with
the results from Cytb-PCR of DNA extracted from blood
samples as the reference standard. Performance indices were
the number of true positives (TPs), number of true negatives
(TNs), number of false positives (FPs), and number of false
negatives (FNs). Sensitivity was expressed as TPs/
(TPs + FNs), and speciﬁcity as TNs/(TPs + FPs). The likeli-
hood ratios were calculated as sensitivity/(1 – speciﬁcity) for
a positive test result, and as (1 – sensitivity)/speciﬁcity for a
negative test result[18]. The two-tailed McNemar test was
used to assess the signiﬁcance of differences between the
sensitivities of each pair of tests.
Results
Detection limit and speciﬁcity of Cytb-PCR
Cytb-PCRs generated PCR fragments of 148, 181, 138, 137
and 131 bp that were speciﬁc for P. falciparum, P. vivax,
P. malariae, P. ovale, and P. knowlesi, respectively (Fig. 1). Cytb-
PCR could reproducibly amplify DNA templates of each
malarial species equivalent to ten copies/lL. When one
copy/lL of DNA was used as template in ten separate reac-
tions, positive results were obtained in about half of the
assays, possibly because of the stochastic distribution of
DNA in template solutions. The same sensitivity was
observed Cytb-PCR of each malarial species, and was repro-
ducible in three independent evaluations. The sensitivity
remained unaltered when numerous of DNA templates from
other malaria species were added to the reactions (data not
shown). Likewise, genomic DNA of P. falciparum equivalent
to a single parasite could be repeatedly ampliﬁed. No false
ampliﬁcation was obtained when genomic DNA did not
match with species-speciﬁc primers of the assay.
Cytb-PCR vs. 18S-PCR for malarial DNA in blood samples
Among 693 blood samples that contained 593 microscopy-
positive samples both Cytb-PCR and 18S-PCR gave concordant
TABLE 1. Primers for mitochondrial Cytb-based diagnostic
PCR for malaria
Target Primers Sequences (5¢ ﬁ 3¢)
Expected
size (bp)
Primary PCR
Plasmodium PCBF ATGCTTTATTATGGATTGGATGTC 226–227
PCBR CAGACCGTAAGGTTATAATTATGT
Secondary PCR
Plasmodium
falciparum
PFCBF ATTATTTATTGTATTATTTTTCTG 148
PFCBR GTATTGAGCGGAACAAATC
Plasmodium
vivax
PVCBF AGTTACCACAAGATATTTTT 181
PVCBR TTGAGCAGAACAATACAG
Plasmodium
malariae
PMCBF ATATCATTCTTTTCTAGTGGT 138
PMCBR CTGTGCAGAACAATACAG
Plasmodium ovale POCBF ATATCATTTTTCTCCAGTGGG 137
POCBR ATGAGCAGAACAATACAG
Plasmodium
knowlesi
PKCBF TATTCTTCTTTAGTGGATTATTTA 131
PKCBR TACACTGATTAGAACAATAC
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results with those of microscopy in 466 isolates (209 P. falci-
parum, 195 P. vivax, 13 co-infections with P. falciparum and
P. vivax, one each for P. malariae and P. ovale, and 47 nega-
tives), or 67.2% of all isolates examined (Table 2). Among
100 microscopy negatives, 18S-PCR and Cytb-PCR detected
malarial DNA in 21 and 54 isolates, respectively, suggesting
submicroscopic malaria infections in these patients (Table 2).
Among 593 microscopy-positive isolates, Cytb-PCR detected
malarial DNA in all except one isolate, whereas 18S-PCR
failed to detect parasites in seven samples (Table 2). Cytb-
PCR was superior to 18S-PCR and microscopy in detecting
each malarial species and mixed-species infections (Table 3).
It is noteworthy that 34% (107/319) and 17% (43/254) of
P. falciparum and P. vivax mono-infections, respectively,
detected by microscopy were, in fact, mixed P. falciparum
and P. non-falciparum infections (Table 1). For all Plasmodium
species, Cytb-PCR was 16% and 39.8% more sensitive than
18S-PCR and microscopy, respectively (Table 3). Further-
more, Cytb-PCR substantially outperformed microscopy in
detecting malaria cases and diagnosing mixed-species infec-
tions, giving efﬁcacy ratios of 1.088 and 9.4, respectively
(Table 3).
Diagnostic performance of Cytb-PCR of saliva and urine
Among 157 matched blood, saliva and urine samples, micro-
scopy identiﬁed 117 malaria patients: P. falciparum (n = 60),
P. vivax (n = 50), P. malariae (n = 2), and co-infection with
1 2 3 4 5 6 7 8
bp
500
200
100
FIG. 1. Representative 4% agarose gel electrophoresis of nested
PCR targeting the mitochondrial cytochrome b gene of human
malarial parasites and Plasmodium knowlesi. Speciﬁc ampliﬁcations
were generated from secondary PCR with species-speciﬁc primers.
Lane 1: 100-bp ladder marker. Lanes 2–6: Plasmodium falciparum
(148 bp), Plasmodium malariae (138 bp), Plasmodium ovale (137 bp),
Plasmodium vivax (181 bp) and P. knowlesi (131 bp), respectively.
Lane 7: human DNA. Lane 8: water control.
TABLE 2. Microscopy and nested PCR targeting mitochondrial Cytb (Cytb-PCR) and 18S rRNA (18S-PCR) of Plasmodium in
blood samples
Method Result
Microscopy (n = 693)
Plasmodium
falciparum
Plasmodium
vivax
Plasmodium
falciparum +
P. vivax
Plasmodium
malariae
Plasmodium
ovale Negative Total
18S-PCR P. falciparum 243 0 0 0 0 8 251
P. vivax 0 224 0 0 0 13 237
P. malariae 0 2 0 2 0 0 4
P. ovale 0 1 0 0 1 0 2
P. knowlesi 0 0 0 2 0 0 2
P. falciparum + P. vivax 65 18 13 0 0 5 101
P. falciparum + P. malariae 4 0 0 0 0 0 4
P. falciparum + P. ovale 2 0 0 0 0 0 2
P. vivax + P. malariae 0 4 0 0 0 0 4
P. vivax + P. ovale 0 1 0 0 0 0 1
P. vivax + P. knowlesi 0 2 0 0 0 0 2
P. falciparum + P. vivax + P. malariae 1 0 0 0 0 0 1
P. falciparum + P. vivax + P. ovale 1 0 0 0 0 0 1
Negative 3 2 0 2 0 74 81
Cytb-PCR P. falciparum 212 0 0 0 0 21 233
P. vivax 0 197 0 0 0 19 216
P. malariae 0 1 0 3 0 0 4
P. ovale 0 1 0 0 1 0 2
P. knowlesi 0 0 0 2 0 0 2
P. falciparum + P. vivax 94 42 13 0 0 13 162
P. falciparum + P. malariae 4 0 0 0 0 0 4
P. falciparum + P. ovale 3 0 0 0 0 0 3
P. falciparum + P. knowlesi 1 0 0 1 0 0 2
P. vivax+ P. malariae 0 7 0 0 0 0 7
P. vivax + P. ovale 0 1 0 0 0 0 1
P. vivax + P. knowlesi 0 3 0 0 0 0 3
P. falciparum + P. vivax + P. malariae 2 1 0 0 0 0 3
P. falciparum + P. vivax + P. ovale 2 0 0 0 0 0 2
P. falciparum + P. malariae + P. ovale 1 0 0 0 0 0 1
Negative 0 1 0 0 0 47 48
Total 319 254 13 6 1 100 693
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P. falciparum and P. vivax (n = 5). Among these, Cytb-PCR
detected malarial parasites in 134 blood samples (55 P. falci-
parum, 43 P. vivax, 34 co-infections with P. falciparum and
P. vivax, and one each for P. malariae and P. knowlesi), 116 sal-
iva samples (53 P. falciparum, 48 P. vivax, 13 co-infections
with P. falciparum and P. vivax, and one each for P. malariae
and P. knowlesi), and 83 urine samples (38 P. falciparum, 32
P. vivax, 11 co-infections with P. falciparum and P. vivax, and
one each for P. malariae and P. knowlesi). On the other hand,
18S-PCR of blood, saliva and urine samples gave positive
results in 119, 86 and 33 samples, respectively.
Considering Cytb-PCR of blood as a reference, the sensi-
tivities of Cytb-PCR of saliva, urine and combined positive
results from saliva and urine were substantially superior to
the corresponding values with 18S-PCR. Although Cytb-PCR
of urine was signiﬁcantly less sensitive than microscopy, Cytb-
PCR of saliva pe se was slightly better than microscopy, with
no signiﬁcant difference (Tables 4 and 5). Importantly, com-
bined positive results from Cytb-PCR of saliva and of urine
yielded signiﬁcantly superior sensitivity to microscopy
(p 0.0098 for P. falciparum and p 0.006 for P. vivax) (Table 4).
Although the likelihood ratios of the positive test results
were high (from 11.4 to inﬁnity), as shown in Table 4, com-
bined results from Cytb-PCR of saliva and urine offered the
lowest likelihood ratios of the negative test results. Further-
more, combined Cytb-PCR of saliva and urine provided bet-
ter sensitivity than microscopy in detecting mixed-species
infections. Both P. malariae and P. knowlesi could be identiﬁed
by Cytb-PCR of blood, saliva and urine of infected individuals,
whereas positive results were obtained with 18S-PCR of
blood but not of saliva and urine.
Parasite density and positive rates of Cytb-PCR of saliva and
urine
To further investigate whether the performance of Cytb-PCR
of saliva and of urine was determined by parasitaemia, we
compared the positive rates of these PCR assays with para-
site densities of P. falciparum (49 positives and six negatives
by microscopy) and P. vivax (37 positives and six negatives by
microscopy) mono-infections as conﬁrmed by Cytb-PCR of
blood (Fig. 2). The geometric mean parasite densities of
microscopically patent P. falciparum and P. vivax were 8948
parasites/lL (range, 35–217 805 parasites/lL) and 3888
parasites/lL (range, 35–44 520 parasites/lL), respectively.
For P. vivax, the positive rates by Cytb-PCR of saliva reached
100% even when the parasite density was <1000 parasites/
lL, whereas Cytb-PCR of urine gave a maximum positive rate
of 75% for this level of parasite density, and remained almost
unchanged despite increasing parasitaemia. No correlation
between parasite density and positive rates by Cytb-PCR of
saliva (r = 0.561, p 0.33) and of urine (r = 0.551, p 0.32) was
found. For P. falciparum, the positive rates by Cytb-PCR of
urine correlated signiﬁcantly with parasite densitity (r = 0.95,
TABLE 3. Comparative detection of human malaria and
Plasmodium knowlesi in 693 blood samples by microscopy,
nested PCR targeting small-subunit rRNA (18S-PCR), and
nested PCR targeting mitochondrial CytB (Cytb-PCR)
Category
Microscopy 18S-PCR Cytb-PCR
No.
positive
No.
positive
Efﬁcacy
ratioa
No.
positive
Efﬁcacy
ratiob
Efﬁcacy
ratioc
Plasmodium
falciparum
332 360 1.084 419 1.262 1.164
Plasmodium vivax 267 347 1.300 395 1.479 1.138
Plasmodium malariae 6 13 2.167 18 3.000 1.385
Plasmodium ovale 1 6 6.000 8 8.000 1.333
Plasmodium knowlesi 0 4 * 7 * 1.750
All species 606 730 1.205 847 1.398 1.160
Co-infections
Two species 13 114 8.769 179 13.769 1.570
Three species 0 2 * 6 * 3.000
Total diagnosed
malaria cases
593 612 1.032 645 1.088 1.054
Total cases with
mixed infections
20 116 5.800 188 9.400 1.603
aRatio of 18S-PCR/microscopy positives.
bRatio of Cytb-PCR/microscopy positives.
cRatio of Cytb-PCR/18S-PCR positives.
*Denominator is zero.
TABLE 4. Diagnostic performance
of microscopy, nested PCR target-
ing mitochondrial Cytb and nested
PCR targeting 18S rRNA in saliva
and urine samples
Method/specimen
(n = 156)
Category %
Sensitivity
%
Speciﬁcity
Likelihood ratio
Positive test Negative test
Microscopy Plasmodium
falciparum
73.0 100 * 0.27
Plasmodium vivax 71.4 100 * 0.29
Cytb-PCR (18S-PCR)
Saliva
+ urine
P. falciparum 85.4 (59.6) 100 (100) * (*) 0.15 (0.40)
P. vivax 84.4 (63.6) 97.5 (98.8) 33.8 (50.9) 0.16 (0.37)
Saliva P. falciparum 74.2 (52.8) 100 (100) * (*) 0.26 (0.47)
P. vivax 79.2 (61.0) 98.7 (100) 63.4 (*) 0.21 (0.39)
Urine P. falciparum 55.1 (25.8) 100 (100) * (*) 0.45 (0.74)
P. vivax 53.3 (14.3) 97.5 (98.8) 21.3 (11.4) 0.48 (0.87)
Cytb-PCR results from blood are used as the reference standard.
*Denominator is zero.
Values in paranthesis are from 18S-PCR.
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p 0.014), whereas no such correlation was observed
between positive rates by Cytb-PCR of saliva and parasite
density (r = 0.712, p 0.18). Cytb-PCR of saliva could detect
either P. falciparum or P. vivax in patients with submicro-
scopic parasitaemia, albeit with positive rates £50%. Com-
bined positive results from Cytb-PCR of saliva and of urine
exhibited slightly more positive rates than Cytb-PCR of saliva
per se (Fig. 2).
Discussion
The Cytb-PCR developed in this study could detect as few as
one to ten copies of the gene target. Performance assess-
ment of Cytb-PCR of blood revealed signiﬁcantly higher sensi-
tivity than that of 18S-PCR (v2 = 6.125, 1 d.f., p 0.0133),
which could result from the presence of a higher copy num-
ber per cell of the former gene target (30–100 copies) than
of the latter (4–8 copies) [10–12]. The presence of malarial
DNA in saliva and urine of malaria patients in different ende-
mic areas implies that the release of malarial DNA in these
body ﬂuids could be a general phenomenon during the
course of infections [8,9]. Quantitative real-time PCR analysis
revealed that the amount of P. falciparum DNA in the circula-
tion was approximately 600-fold greater than that in saliva
and approximately 2500-fold greater than that in urine [9].
Although the range of submicroscopic levels of P. falciparum
in patients in this study was unknown, the positive rate for
either P. falciparum or P. vivax by Cytb-PCR of saliva was
approximately two-fold to four-fold greater than that with
Cytb-PCR of urine. Interestingly, the ratio of positive rates by
Cytb-PCR of saliva to Cytb-PCR of urine of those infected
with P. falciparum with <1000 parasites/lL was also approxi-
mately three, which is in close agreement with the ratio of
amounts of DNA in saliva and urine (approximately four)
quantiﬁed in another study [9]. Also, P. falciparum DNA in
saliva and urine was reportedly dependent on the parasite
density in the circulation [9]. Our analysis has shown a signif-
icant correlation between blood parasite density and positive
rates by Cytb-PCR of urine but not of saliva for P. falciparum,
which could result from differences in the pattern of release
of DNA, dilution effects of these body ﬂuids, or simply the
small number of samples analysed.
The highly sensitive PCR assay might be subject to arte-
factual DNA ampliﬁcation, which could have arisen for vari-
ous reasons. Some of the most frequently encountered
problems were carryover contamination and cross-hybridiza-
tion between primers and variant forms of DNA templates
TABLE 5. Comparative diagnostic sensitivity between detection methods (p-values) for Plasmodium falciparum (lower diagonal)
and Plasmodium vivax (upper diagonal)
Method Microscopy Cytb-PCR-B Cytb-PCR-S Cytb-PCR-U Cytb-PCR-SU
Microscopy <0.0001 0.1456 0.0190 0.0060
Cytb-PCR-B <0.0001 0.0007 <0.0001 0.0162
Cytb-PCR-S 1.0000 <0.0001 0.0008 0.0736
Cytb-PCR-U 0.0062 <0.0001 0.0085 <0.0001
Cytb-PCR-SU 0.0098 0.0009 0.0044 <0.0001
Cytb-PCR, nested PCR targeting mitochondrial Cytb; Cytb-PCR-B, Cytb-PCR of blood; Cytb-PCR-S, Cytb-PCR of saliva; Cytb-PCR-U, Cytb-PCR of urine; Cytb-PCR-SU, combined
positives from nested Cytb-PCR of saliva and of urine.
Bold denotes a non-signiﬁcant difference according to the two-tailed McNemar test.
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FIG. 2. Relationship between parasite density and positive rates of
Plasmodium falciparum (ﬁlled bars) and Plasmodium vivax (upward diag-
onal bars) by nested PCR targeting the mitochondrial cytochrome b
gene (Cytb-PCR) of saliva (A), urine (B) and combined saliva and
urine (C).
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[19]. In our PCR assay, we monitored carryover contamina-
tion and the speciﬁcity of diagnostic PCR primers by incor-
porating negative controls comprising DNA from healthy
donors and positive control DNA from each malarial species,
respectively, in separate reaction tubes for every 15 tested
samples. Furthermore, the 3¢-nucleotides of all species-spe-
ciﬁc inner PCR primers differed from those of other species,
resulting in a lower chance of initiation of primer extension
for DNA from mismatched species [20]. Therefore, it is unli-
kely that the high sensitivity of the Cytb-PCR developed
herein would be compromised by such common PCR arte-
facts. On the other hand, the negative results with Cytb-PCR
or 18S-PCR of saliva and urine seem unlikely to be attribut-
able to the presence of PCR inhibitors in these samples,
because positive results were subsequently obtained after
addition of malarial DNA templates. Furthermore, the high
sensitivity of Cytb-PCR, which is capable of detecting one
copy of the gene target of each malarial species, makes it
unlikely that the diagnostic performance reported herein has
been biased by non-systematic sampling in this study.
Conclusion
The Cytb-PCR developed in this study could sensitively
detect and speciﬁcally differentiate ﬁve human malarial spe-
cies in blood, and was superior to 18S-PCR, meaning that
the diagnostic performance of Cytb-PCR of saliva and urine
could be of practical value. The presence of P. knowlesi and
P. malariae DNA in saliva and urine further suggests the
potential application of these samples for the diagnosis of
malarial species besides P. falciparum and P. vivax.
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